January 26, 2012 — The RhinoChill IntraNasal cooling system has been nominated for one of the European medical device industry’s most prestigious awards.
January 26, 2012 — Amorcyte LLC, a NeoStem company, announced the enrollment of the first patient in the Amorcyte PreSERVE Phase II trial for acute myocardial infarction. The study is a multicenter, randomized, double-blind, placebo-controlled clinical trial to evaluate the safety and efficacy of infarct-related artery infusion of AMR-001, an autologous bone marrow derived cell therapy enriched for CD34+ cells.
January 25, 2012 — CJPS Medical Systems announced that VitalPoint, its remote patient monitor, can be used with Microsoft Windows-based tablet PCs. This announcement comes on the heels of CJPS being the first company to waive all connectivity fees to caregivers accessing their patients' data remotely using home monitors.
January 25, 2012 — CardioFocus, Inc. developer of the HeartLight Endoscopic Ablation System (EAS) for the treatment of atrial fibrillation (AF) announced that a new study in the Journal of Cardiovascular Electrophysiology demonstrated the high acute and chronic success rates achievable with a single AF ablation procedure using HeartLight EAS.
January 25, 2012 — Terumo Cardiovascular Systems announced today that it has entered into an exclusive agreement with LAAx Inc. to distribute the TigerPaw System II, a left atrial appendage (LAA) closure device in the United States.
January 25, 2012 — Physicians at University Hospitals (UH) Case Medical Center enrolled their first patient in LEVANT 2, a global, multicenter, randomized clinical trial evaluating the safety and efficacy of the Moxy drug-coated balloon for the treatment of peripheral arterial disease (PAD).
